findmyKOL
Clinical trialNCT02852005CompletedPhase 1Interventional

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment27HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the AIDSVAX B/E vaccine and the MVA/HIV62B vaccine in healthy, HIV-1-uninfected adults who previously received MVA/HIV62B in DNA/MVA or MVA/MVA vaccine regimens in the HVTN 205 study.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Peru
  • Acsa Crs

    Iquitos, Maynas, Peru

  • Barranco Crs

    Lima, Peru

United States
  • Alabama Crs

    Birmingham, Alabama, United States

  • Bridge Hiv Crs

    San Francisco, California, United States

  • the Hope Clinic of the Emory Vaccine Center Crs

    Decatur, Georgia, United States

  • Brigham and Women'S Hospital Vaccine Crs (bwh Vcrs)

    Boston, Massachusetts, United States

  • Columbia P&s Crs

    New York, New York, United States

  • University of Rochester Vaccines To Prevent Hiv Infection Crs

    Rochester, New York, United States

  • Seattle Vaccine and Prevention Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AIDSVAX B/E vaccineVaccinia virusPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2017
Primary completion
29 Aug 2018
Completion
29 Oct 2019
Last update posted
8 Aug 2022
Registered enrollment
27
Registry id
NCT02852005
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.